General information

Title
Project of University Development Cooperation - Own Initiative 2011 - Molecular characterization and valorization of Cuban natural products :Vimang® and its naturally glucosylxanthone mangiferin, for therapeutic applications against cancer and inflammation
ID
XM-DAC-2-10-3011678
CRS ID
2019CO1678
Start date
End date
Activity status
Completion
Budget
€299.574
Actor
VLIR-UOS - Vlaamse Interuniversitaire Raad - Flemish Interuniversity Council
Country
CUBA
Sector
Health - Medical research
Aid type
Core support to NGOs, other private bodies, PPPs and research institutes
Fragile state
No
Least developed country
No
Budgetline
54 24 452353 (ex 54443553) VLIR's own initiatives
Finance type
GRANT
Tied status
No
Flow type
ODA

General

Developmental overall objective (benefits for the society): A phytomedicinal compound from natural resources and a classical therapeutic agent have been combined into a novel sustainable cost-effective cancer therapy in Cuba Academic overall objective (related to the capacity building of the university): Capacity for cancer studies with natural compounds has been improved for Cuban researchers

Results

Developmental specific objectives: Solid scientific support for mangiferin as a sustainable cost-effective natural phytomedicinal anti-cancer compound from natural resources in Cuba has been provided Academic specific objectives: Capacity for molecular cancer research in preclinical models in laboratory animals natural compounds has improved for Cuban researchers

Documents

Related activities

Loading Map Markers, Please Wait

Disclaimer: Country borders do not necessarily reflect the Belgian Government's official position.